L-072-2025

Agreement ID
L-072-2025
Lead IC
NCATS
Exclusivity
Exclusive
External Party
Neurala Bio Inc. (A Civala Company)
Fiscal Year
2025
Territory
Worldwide
Execution Date
Effective Date
Export Date
Technologies
TAB-3547     New Allosteric Inhibitors of C-Abl Tyrosine Kinase for the Treatment of Alzheimer’s and other Neurodegenerative Diseases